Y. Sakakibara, K. Tambara, F. Lu, T. Nishina, G. Sakaguchi, N. Nagaya, K. Nishimura, Ren-Ke Li, R. Weisel, M. Komeda
{"title":"手术修复与细胞移植联合治疗左室动脉瘤的实验研究","authors":"Y. Sakakibara, K. Tambara, F. Lu, T. Nishina, G. Sakaguchi, N. Nagaya, K. Nishimura, Ren-Ke Li, R. Weisel, M. Komeda","doi":"10.1161/01.CIR.0000032905.33237.C7","DOIUrl":null,"url":null,"abstract":"BackgroundThis study was designed to investigate the efficacy of the combined procedure of left ventricular (LV) repair and fetal cardiomyocyte transplantation (CM-TX) in a rat myocardial infarction model. Methods and ResultsA moderate-sized LV aneurysm was created by proximal ligation of the left coronary artery in 47 Lewis rats. Four weeks later, they were underwent another operation and received culture medium injection (n=10; group I), fetal CM-TX (n=10; group II), purse-string LV repair with culture medium injection (n=14; group III), or LV repair with fetal CM-TX (n=13; group IV). They were echocardiographically followed-up during the subsequent 4 weeks, and cardiac catheterization was performed in the final week. In the late period, LV dimension in group IV was smaller than that in group III (end-diastolic dimension, 0.92±0.02 versus 1.01±0.03 cm, P= 0.0090; end-systolic dimension, 0.62±0.02 versus 0.74±0.04 cm, P= 0.0093; at the fourth week), although they initially showed similar decreases in both groups. At the final week, end-systolic elastance was higher in group IV than in groups I, II, or III (0.61±0.10 versus 0.19±0.03, 0.30±0.09, 0.33±0.07 mm Hg/&mgr;L, P= 0.0002, 0.0037, and 0.0042, respectively). ConclusionsFetal CM-TX exerted preventive effects against late LV dilation and dysfunction after LV repair in the rat model. The results suggest that repair surgery combined with fetal CM-TX may enhance the surgical benefits for patients with LV aneurysm in the long term.","PeriodicalId":10194,"journal":{"name":"Circulation: Journal of the American Heart Association","volume":"10 1","pages":"I-193-I-197"},"PeriodicalIF":0.0000,"publicationDate":"2002-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"33","resultStr":"{\"title\":\"Combined Procedure of Surgical Repair and Cell Transplantation for Left Ventricular Aneurysm: An Experimental Study\",\"authors\":\"Y. Sakakibara, K. Tambara, F. Lu, T. Nishina, G. Sakaguchi, N. Nagaya, K. Nishimura, Ren-Ke Li, R. Weisel, M. Komeda\",\"doi\":\"10.1161/01.CIR.0000032905.33237.C7\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"BackgroundThis study was designed to investigate the efficacy of the combined procedure of left ventricular (LV) repair and fetal cardiomyocyte transplantation (CM-TX) in a rat myocardial infarction model. Methods and ResultsA moderate-sized LV aneurysm was created by proximal ligation of the left coronary artery in 47 Lewis rats. Four weeks later, they were underwent another operation and received culture medium injection (n=10; group I), fetal CM-TX (n=10; group II), purse-string LV repair with culture medium injection (n=14; group III), or LV repair with fetal CM-TX (n=13; group IV). They were echocardiographically followed-up during the subsequent 4 weeks, and cardiac catheterization was performed in the final week. In the late period, LV dimension in group IV was smaller than that in group III (end-diastolic dimension, 0.92±0.02 versus 1.01±0.03 cm, P= 0.0090; end-systolic dimension, 0.62±0.02 versus 0.74±0.04 cm, P= 0.0093; at the fourth week), although they initially showed similar decreases in both groups. At the final week, end-systolic elastance was higher in group IV than in groups I, II, or III (0.61±0.10 versus 0.19±0.03, 0.30±0.09, 0.33±0.07 mm Hg/&mgr;L, P= 0.0002, 0.0037, and 0.0042, respectively). ConclusionsFetal CM-TX exerted preventive effects against late LV dilation and dysfunction after LV repair in the rat model. The results suggest that repair surgery combined with fetal CM-TX may enhance the surgical benefits for patients with LV aneurysm in the long term.\",\"PeriodicalId\":10194,\"journal\":{\"name\":\"Circulation: Journal of the American Heart Association\",\"volume\":\"10 1\",\"pages\":\"I-193-I-197\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2002-09-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"33\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Circulation: Journal of the American Heart Association\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1161/01.CIR.0000032905.33237.C7\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Circulation: Journal of the American Heart Association","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1161/01.CIR.0000032905.33237.C7","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 33
摘要
本研究旨在探讨左心室(LV)修复和胎儿心肌细胞移植(CM-TX)联合治疗大鼠心肌梗死模型的疗效。方法与结果47只Lewis大鼠采用左冠状动脉近端结扎术制造中等大小左室动脉瘤。4周后再次手术并注射培养基(n=10;I组),胎儿CM-TX (n=10;II组)、荷包包注射培养基修复LV (n=14;III组)或胎儿CM-TX修复左室(n=13;IV组)。术后4周超声心动图随访,最后一周行心导管插管。晚期IV组左室径小于III组(舒张末期径,0.92±0.02 vs 1.01±0.03 cm, P= 0.0090;收缩期末尺寸:0.62±0.02 vs 0.74±0.04 cm, P= 0.0093;在第四周),尽管他们最初在两组中表现出相似的下降。在最后一周,IV组的收缩末期弹性高于I、II或III组(0.61±0.10 vs 0.19±0.03、0.30±0.09、0.33±0.07 mmhg /&mgr;L, P分别= 0.0002、0.0037和0.0042)。结论胎儿CM-TX对大鼠左室晚期扩张和左室修复后功能障碍具有预防作用。结果表明,修复手术联合胎儿CM-TX可长期提高左室动脉瘤患者的手术效益。
Combined Procedure of Surgical Repair and Cell Transplantation for Left Ventricular Aneurysm: An Experimental Study
BackgroundThis study was designed to investigate the efficacy of the combined procedure of left ventricular (LV) repair and fetal cardiomyocyte transplantation (CM-TX) in a rat myocardial infarction model. Methods and ResultsA moderate-sized LV aneurysm was created by proximal ligation of the left coronary artery in 47 Lewis rats. Four weeks later, they were underwent another operation and received culture medium injection (n=10; group I), fetal CM-TX (n=10; group II), purse-string LV repair with culture medium injection (n=14; group III), or LV repair with fetal CM-TX (n=13; group IV). They were echocardiographically followed-up during the subsequent 4 weeks, and cardiac catheterization was performed in the final week. In the late period, LV dimension in group IV was smaller than that in group III (end-diastolic dimension, 0.92±0.02 versus 1.01±0.03 cm, P= 0.0090; end-systolic dimension, 0.62±0.02 versus 0.74±0.04 cm, P= 0.0093; at the fourth week), although they initially showed similar decreases in both groups. At the final week, end-systolic elastance was higher in group IV than in groups I, II, or III (0.61±0.10 versus 0.19±0.03, 0.30±0.09, 0.33±0.07 mm Hg/&mgr;L, P= 0.0002, 0.0037, and 0.0042, respectively). ConclusionsFetal CM-TX exerted preventive effects against late LV dilation and dysfunction after LV repair in the rat model. The results suggest that repair surgery combined with fetal CM-TX may enhance the surgical benefits for patients with LV aneurysm in the long term.